PBMs, FTC and IRA: Experts Tackle Pharma’s Tough Acronyms At BioFuture Conference

 
• By Jessica Merrill

Some of the industry’s biggest challenges, and potential solutions, were hot topics at the BioFuture conference in New York.

A member of Congress said during the conference that he was sympathetic to industry efforts to change the time before drugs and biologics are subject to price negotiations. (Shutterstock)

More from PBMs

More from Elections